

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | valine metabolic process (GO:0006573) | 5.19032557 |
| 2 | immunoglobulin mediated immune response (GO:0016064) | 5.06553818 |
| 3 | detection of other organism (GO:0098543) | 4.58804987 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 4.53516433 |
| 5 | detection of bacterium (GO:0016045) | 4.50352065 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.33973172 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33973172 |
| 8 | pentose-phosphate shunt (GO:0006098) | 4.32826710 |
| 9 | type I interferon signaling pathway (GO:0060337) | 4.21009717 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.21009717 |
| 11 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.20544672 |
| 12 | response to type I interferon (GO:0034340) | 4.17831770 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.16481404 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.10911332 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 4.03861932 |
| 16 | NADPH regeneration (GO:0006740) | 4.03851624 |
| 17 | negative regulation of phagocytosis (GO:0050765) | 3.96792697 |
| 18 | B cell mediated immunity (GO:0019724) | 3.94057924 |
| 19 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.91688466 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 3.85676713 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.82774169 |
| 22 | fatty acid beta-oxidation (GO:0006635) | 3.81458711 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.78236249 |
| 24 | macrophage differentiation (GO:0030225) | 3.73124764 |
| 25 | regulation of cholesterol storage (GO:0010885) | 3.72650989 |
| 26 | regulation of antigen processing and presentation (GO:0002577) | 3.67966412 |
| 27 | positive regulation of type 2 immune response (GO:0002830) | 3.65194277 |
| 28 | T-helper 1 type immune response (GO:0042088) | 3.63014595 |
| 29 | thrombin receptor signaling pathway (GO:0070493) | 3.60700849 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.59536036 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.59381228 |
| 32 | fatty acid oxidation (GO:0019395) | 3.58210275 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.57699929 |
| 34 | pentose metabolic process (GO:0019321) | 3.52154492 |
| 35 | lipid oxidation (GO:0034440) | 3.52134755 |
| 36 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.51276601 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.50287993 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50116160 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50116160 |
| 40 | apoptotic cell clearance (GO:0043277) | 3.46968044 |
| 41 | low-density lipoprotein particle clearance (GO:0034383) | 3.44922179 |
| 42 | germinal center formation (GO:0002467) | 3.44752923 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44400654 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.44400654 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44400654 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44400654 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44400654 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.44400654 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.43161829 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.43060361 |
| 51 | toxin transport (GO:1901998) | 3.42600710 |
| 52 | branched-chain amino acid metabolic process (GO:0009081) | 3.41819915 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.41221911 |
| 54 | tricarboxylic acid metabolic process (GO:0072350) | 3.39730381 |
| 55 | fatty acid catabolic process (GO:0009062) | 3.38388971 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.37733783 |
| 57 | detection of biotic stimulus (GO:0009595) | 3.37648552 |
| 58 | leukocyte aggregation (GO:0070486) | 3.35730499 |
| 59 | defense response to fungus (GO:0050832) | 3.32231945 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31666281 |
| 61 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.31533740 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.30198974 |
| 63 | myeloid dendritic cell activation (GO:0001773) | 3.29474611 |
| 64 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.27959578 |
| 65 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.27959578 |
| 66 | response to protozoan (GO:0001562) | 3.27427453 |
| 67 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.24796892 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.24491539 |
| 69 | cellular response to interferon-gamma (GO:0071346) | 3.24321223 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23893144 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 3.23826645 |
| 72 | brown fat cell differentiation (GO:0050873) | 3.23729890 |
| 73 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23672891 |
| 74 | regulation of type 2 immune response (GO:0002828) | 3.23202351 |
| 75 | alpha-linolenic acid metabolic process (GO:0036109) | 3.22132244 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 3.21844361 |
| 77 | NIK/NF-kappaB signaling (GO:0038061) | 3.21665120 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 3.20308353 |
| 79 | defense response to protozoan (GO:0042832) | 3.19529008 |
| 80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19235885 |
| 81 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.18896680 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16597421 |
| 83 | T cell migration (GO:0072678) | 3.15624390 |
| 84 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14157954 |
| 85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.13724203 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13352812 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 3.13352812 |
| 88 | negative thymic T cell selection (GO:0045060) | 3.11126367 |
| 89 | positive regulation of fatty acid oxidation (GO:0046321) | 3.10845940 |
| 90 | NADP metabolic process (GO:0006739) | 3.10378809 |
| 91 | cellular extravasation (GO:0045123) | 3.10243147 |
| 92 | regulation of tolerance induction (GO:0002643) | 3.10038364 |
| 93 | regulation of hypersensitivity (GO:0002883) | 3.09038311 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07591697 |
| 95 | lysine metabolic process (GO:0006553) | 3.06976332 |
| 96 | lysine catabolic process (GO:0006554) | 3.06976332 |
| 97 | response to interferon-gamma (GO:0034341) | 3.05745264 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.05573800 |
| 99 | response to peptidoglycan (GO:0032494) | 3.05408236 |
| 100 | neutrophil activation (GO:0042119) | 3.05086646 |
| 101 | macrophage activation (GO:0042116) | 3.04313893 |
| 102 | microglial cell activation (GO:0001774) | 3.02727812 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 3.02680219 |
| 104 | branched-chain amino acid catabolic process (GO:0009083) | 3.01636397 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00768060 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 3.00012367 |
| 107 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.99875769 |
| 108 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97568464 |
| 109 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.95509092 |
| 110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.93907623 |
| 111 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.92854748 |
| 112 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.91877362 |
| 113 | neutrophil mediated immunity (GO:0002446) | 2.91791112 |
| 114 | mannose metabolic process (GO:0006013) | 2.91437464 |
| 115 | respiratory burst (GO:0045730) | 2.90109435 |
| 116 | sodium-independent organic anion transport (GO:0043252) | 2.89757138 |
| 117 | glucose catabolic process (GO:0006007) | 2.89087102 |
| 118 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.89085282 |
| 119 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.88698232 |
| 120 | definitive hemopoiesis (GO:0060216) | 2.88588987 |
| 121 | lipid storage (GO:0019915) | 2.88054345 |
| 122 | negative regulation of lipid storage (GO:0010888) | 2.87511125 |
| 123 | negative T cell selection (GO:0043383) | 2.86348690 |
| 124 | monocarboxylic acid catabolic process (GO:0072329) | 2.85383585 |
| 125 | granulocyte activation (GO:0036230) | 2.85165000 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.83471186 |
| 127 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83117608 |
| 128 | protein carboxylation (GO:0018214) | 2.82981215 |
| 129 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82981215 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.82919382 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82610149 |
| 132 | positive thymic T cell selection (GO:0045059) | 2.82371485 |
| 133 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81589966 |
| 134 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80302784 |
| 135 | white fat cell differentiation (GO:0050872) | 2.80106861 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79881462 |
| 137 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79865223 |
| 138 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.79842096 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.79281533 |
| 140 | regulation of fatty acid oxidation (GO:0046320) | 2.78860826 |
| 141 | cellular response to zinc ion (GO:0071294) | 2.77727186 |
| 142 | regulation of B cell differentiation (GO:0045577) | 2.76587327 |
| 143 | response to fungus (GO:0009620) | 2.76322461 |
| 144 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.75701029 |
| 145 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.75446161 |
| 146 | drug transmembrane transport (GO:0006855) | 2.74603725 |
| 147 | oxaloacetate metabolic process (GO:0006107) | 2.74534944 |
| 148 | primary alcohol catabolic process (GO:0034310) | 2.72796783 |
| 149 | response to muramyl dipeptide (GO:0032495) | 2.72368670 |
| 150 | regulation of natural killer cell differentiation (GO:0032823) | 2.70887871 |
| 151 | carnitine metabolic process (GO:0009437) | 2.69268717 |
| 152 | drug transport (GO:0015893) | 2.68269589 |
| 153 | positive regulation of lipid catabolic process (GO:0050996) | 2.62587042 |
| 154 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62393439 |
| 155 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62151277 |
| 156 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60859436 |
| 157 | glyoxylate metabolic process (GO:0046487) | 2.60652491 |
| 158 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57681099 |
| 159 | response to host immune response (GO:0052572) | 2.57681099 |
| 160 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.56971701 |
| 161 | response to host (GO:0075136) | 2.56971701 |
| 162 | response to host defenses (GO:0052200) | 2.56971701 |
| 163 | fatty acid transmembrane transport (GO:1902001) | 2.55823340 |
| 164 | quaternary ammonium group transport (GO:0015697) | 2.55206755 |
| 165 | positive regulation of sterol transport (GO:0032373) | 2.54777670 |
| 166 | positive regulation of cholesterol transport (GO:0032376) | 2.54777670 |
| 167 | regulation of triglyceride catabolic process (GO:0010896) | 2.54211787 |
| 168 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53652008 |
| 169 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.50621072 |
| 170 | sulfur amino acid catabolic process (GO:0000098) | 2.50584505 |
| 171 | biotin metabolic process (GO:0006768) | 2.49509805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.28128757 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.12645343 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.33309364 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15542143 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.14505946 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00096059 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.91192773 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85205787 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82299996 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.78201935 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65762264 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47089537 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45264500 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44564057 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.32859299 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31368564 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27500352 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24993343 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19486317 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.15399536 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15289080 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14088629 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12555116 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11420354 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07877058 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99344589 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.89280556 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87516931 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86239408 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83536817 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73147682 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73137668 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.72655321 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.67997955 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64135523 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61595911 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61144036 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57864025 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56077212 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55429896 |
| 41 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54797246 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49170861 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46319866 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44535363 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44243835 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43429929 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42755292 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42460937 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41278418 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40924901 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40500842 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40010184 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37946802 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.37866238 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37436744 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37030694 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35089415 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33329175 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33327970 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32649448 |
| 61 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32585024 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31483501 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31360061 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30977390 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30412051 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30114503 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26041776 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25069740 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.24957471 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24656200 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23320737 |
| 72 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21317817 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19269129 |
| 74 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18382858 |
| 75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18217181 |
| 76 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17865584 |
| 77 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.17736088 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17592209 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16241153 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15982938 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15361204 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15181204 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14993257 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13951041 |
| 85 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13597221 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13572240 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13451740 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11668335 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11142774 |
| 90 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10591967 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10120062 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09272516 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08575355 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06959992 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06502646 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04542235 |
| 97 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04063718 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 1.03857344 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03682018 |
| 100 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03619531 |
| 101 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02822469 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01847407 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01507809 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00861853 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00805999 |
| 106 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.99495202 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98104156 |
| 108 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98014762 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97752180 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97412236 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96936830 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95670497 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95547656 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94981674 |
| 115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94916294 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94671259 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94339110 |
| 118 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94129222 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93914840 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89714057 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79412080 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78289120 |
| 123 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77529201 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76340415 |
| 125 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75393756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.32063718 |
| 2 | MP0006082_CNS_inflammation | 3.13475414 |
| 3 | MP0004510_myositis | 2.88818210 |
| 4 | MP0005670_abnormal_white_adipose | 2.85954846 |
| 5 | MP0009840_abnormal_foam_cell | 2.85408091 |
| 6 | MP0003724_increased_susceptibility_to | 2.72812727 |
| 7 | MP0009278_abnormal_bone_marrow | 2.70474910 |
| 8 | MP0003436_decreased_susceptibility_to | 2.64822527 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.21987243 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 2.21667695 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.20033732 |
| 12 | MP0005360_urolithiasis | 2.19231487 |
| 13 | MP0002419_abnormal_innate_immunity | 2.18699517 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.15790717 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.11667347 |
| 16 | MP0003303_peritoneal_inflammation | 2.09395864 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.08693762 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 2.08693762 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.07250036 |
| 20 | MP0005365_abnormal_bile_salt | 2.04840753 |
| 21 | MP0000343_altered_response_to | 2.01819319 |
| 22 | MP0001853_heart_inflammation | 2.01164235 |
| 23 | MP0004130_abnormal_muscle_cell | 1.96478706 |
| 24 | MP0009764_decreased_sensitivity_to | 1.87925851 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.79673618 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.78973509 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.76718279 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.69277104 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.67671192 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.67627125 |
| 31 | MP0008004_abnormal_stomach_pH | 1.66155124 |
| 32 | MP0009785_altered_susceptibility_to | 1.62900783 |
| 33 | MP0005310_abnormal_salivary_gland | 1.60012669 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.59133896 |
| 35 | MP0003075_altered_response_to | 1.58704211 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.57751574 |
| 37 | MP0005025_abnormal_response_to | 1.54382511 |
| 38 | MP0003279_aneurysm | 1.52693756 |
| 39 | MP0000604_amyloidosis | 1.51132424 |
| 40 | MP0005451_abnormal_body_composition | 1.50877141 |
| 41 | MP0003828_pulmonary_edema | 1.42146271 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.41907210 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.41358565 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.41041032 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.40892899 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.40842714 |
| 47 | MP0000858_altered_metastatic_potential | 1.38348180 |
| 48 | MP0002971_abnormal_brown_adipose | 1.37589284 |
| 49 | MP0000609_abnormal_liver_physiology | 1.36242146 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.35369060 |
| 51 | MP0008469_abnormal_protein_level | 1.35192401 |
| 52 | MP0008260_abnormal_autophagy | 1.33527931 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.32751254 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.32513319 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.29216216 |
| 56 | MP0002405_respiratory_system_inflammati | 1.28398581 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.25824286 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.25699748 |
| 59 | MP0005332_abnormal_amino_acid | 1.25161741 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.24222720 |
| 61 | MP0001819_abnormal_immune_cell | 1.23198501 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.22928112 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21662624 |
| 64 | MP0003011_delayed_dark_adaptation | 1.21532608 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.20568676 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 1.20474960 |
| 67 | MP0003448_altered_tumor_morphology | 1.18934751 |
| 68 | MP0001764_abnormal_homeostasis | 1.17256380 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.17125938 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.16458228 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.16143418 |
| 72 | MP0003252_abnormal_bile_duct | 1.16029661 |
| 73 | MP0001800_abnormal_humoral_immune | 1.13393239 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.13168970 |
| 75 | MP0003186_abnormal_redox_activity | 1.12911209 |
| 76 | MP0001958_emphysema | 1.10862397 |
| 77 | MP0002723_abnormal_immune_serum | 1.10605628 |
| 78 | MP0001851_eye_inflammation | 1.09047481 |
| 79 | MP0001790_abnormal_immune_system | 1.08355263 |
| 80 | MP0005387_immune_system_phenotype | 1.08355263 |
| 81 | MP0002933_joint_inflammation | 1.08129856 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.07510612 |
| 83 | MP0005023_abnormal_wound_healing | 1.07439986 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07144802 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06551735 |
| 86 | MP0005334_abnormal_fat_pad | 1.01863436 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.00912590 |
| 88 | MP0003690_abnormal_glial_cell | 1.00572851 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.99143363 |
| 90 | MP0009115_abnormal_fat_cell | 0.99069837 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.98832573 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.98652496 |
| 93 | MP0002254_reproductive_system_inflammat | 0.97691367 |
| 94 | MP0009763_increased_sensitivity_to | 0.97238135 |
| 95 | MP0003866_abnormal_defecation | 0.96385912 |
| 96 | MP0000689_abnormal_spleen_morphology | 0.94654745 |
| 97 | MP0000685_abnormal_immune_system | 0.93062871 |
| 98 | MP0000716_abnormal_immune_system | 0.92887548 |
| 99 | MP0005164_abnormal_response_to | 0.92114994 |
| 100 | MP0002970_abnormal_white_adipose | 0.92050857 |
| 101 | MP0002398_abnormal_bone_marrow | 0.90547595 |
| 102 | MP0000598_abnormal_liver_morphology | 0.90510394 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.90297129 |
| 104 | MP0005390_skeleton_phenotype | 0.89100695 |
| 105 | MP0005671_abnormal_response_to | 0.88863640 |
| 106 | MP0003091_abnormal_cell_migration | 0.88827905 |
| 107 | MP0000920_abnormal_myelination | 0.88725745 |
| 108 | MP0001873_stomach_inflammation | 0.87856146 |
| 109 | MP0005166_decreased_susceptibility_to | 0.86812380 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.86810573 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.85985923 |
| 112 | MP0002429_abnormal_blood_cell | 0.85899758 |
| 113 | MP0004883_abnormal_blood_vessel | 0.85886768 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.85654667 |
| 115 | MP0004947_skin_inflammation | 0.84777429 |
| 116 | MP0002722_abnormal_immune_system | 0.84692177 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.84551640 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.83620437 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.83591369 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.83249801 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.80884153 |
| 122 | MP0008874_decreased_physiological_sensi | 0.79472145 |
| 123 | MP0005647_abnormal_sex_gland | 0.79050100 |
| 124 | MP0000015_abnormal_ear_pigmentation | 0.76606738 |
| 125 | MP0003795_abnormal_bone_structure | 0.75159396 |
| 126 | MP0002132_abnormal_respiratory_system | 0.72667392 |
| 127 | MP0000249_abnormal_blood_vessel | 0.70714783 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.70457667 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.69846341 |
| 130 | MP0001663_abnormal_digestive_system | 0.69246055 |
| 131 | MP0000371_diluted_coat_color | 0.68607654 |
| 132 | MP0002006_tumorigenesis | 0.67248246 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.63446350 |
| 134 | MP0003045_fibrosis | 0.57784406 |
| 135 | MP0001542_abnormal_bone_strength | 0.52624916 |
| 136 | MP0001849_ear_inflammation | 0.51231151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.66698868 |
| 2 | Recurrent cutaneous fungal infections (HP:0011370) | 4.42672478 |
| 3 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.42672478 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.24100020 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.23048101 |
| 6 | Petechiae (HP:0000967) | 4.15753677 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.09422239 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.09422239 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.09422239 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.07828719 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96838202 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.80731241 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.70282268 |
| 14 | Optic neuritis (HP:0100653) | 3.61191251 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.61191251 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.49486210 |
| 17 | Meningitis (HP:0001287) | 3.48867985 |
| 18 | Abnormal platelet volume (HP:0011876) | 3.41313504 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.33521511 |
| 20 | Purpura (HP:0000979) | 3.32913072 |
| 21 | Menorrhagia (HP:0000132) | 3.28877883 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.26071429 |
| 23 | Increased mean platelet volume (HP:0011877) | 3.24049951 |
| 24 | Loss of speech (HP:0002371) | 3.21868188 |
| 25 | Recurrent viral infections (HP:0004429) | 3.21433668 |
| 26 | Stomatitis (HP:0010280) | 3.17923292 |
| 27 | IgM deficiency (HP:0002850) | 3.16327619 |
| 28 | Hemoptysis (HP:0002105) | 3.16123791 |
| 29 | Gingival bleeding (HP:0000225) | 3.14521525 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09405430 |
| 31 | Vasculitis (HP:0002633) | 3.08454840 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08445431 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.04787729 |
| 34 | Generalized aminoaciduria (HP:0002909) | 3.02060405 |
| 35 | Epistaxis (HP:0000421) | 2.98106979 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.93758412 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 2.93294900 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 2.88709644 |
| 39 | Colitis (HP:0002583) | 2.88180194 |
| 40 | Premature loss of primary teeth (HP:0006323) | 2.81772614 |
| 41 | Hyperglycinuria (HP:0003108) | 2.79639467 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.79506130 |
| 43 | Impaired platelet aggregation (HP:0003540) | 2.76388309 |
| 44 | Abnormal platelet function (HP:0011869) | 2.76388309 |
| 45 | Increased IgE level (HP:0003212) | 2.73443261 |
| 46 | Myositis (HP:0100614) | 2.72268793 |
| 47 | Encephalitis (HP:0002383) | 2.70888103 |
| 48 | Pustule (HP:0200039) | 2.67438769 |
| 49 | Disinhibition (HP:0000734) | 2.66394561 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.65336892 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58837642 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.57371005 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56322059 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.53748418 |
| 55 | Joint hemorrhage (HP:0005261) | 2.53309941 |
| 56 | Mutism (HP:0002300) | 2.52301578 |
| 57 | Hyperammonemia (HP:0001987) | 2.51902830 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.48933358 |
| 59 | Ketosis (HP:0001946) | 2.48889483 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.48042726 |
| 61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.48042726 |
| 62 | Increased IgM level (HP:0003496) | 2.46573234 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.45914951 |
| 64 | Nausea (HP:0002018) | 2.45655144 |
| 65 | Multiple enchondromatosis (HP:0005701) | 2.45130022 |
| 66 | Recurrent skin infections (HP:0001581) | 2.44358343 |
| 67 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43672367 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.43362357 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43362357 |
| 70 | Hypertriglyceridemia (HP:0002155) | 2.42419522 |
| 71 | Chest pain (HP:0100749) | 2.41656800 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39889108 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.39889108 |
| 74 | Deep venous thrombosis (HP:0002625) | 2.39080997 |
| 75 | Urticaria (HP:0001025) | 2.38505923 |
| 76 | Myocardial infarction (HP:0001658) | 2.38476663 |
| 77 | Ketoacidosis (HP:0001993) | 2.38344043 |
| 78 | Spondylolisthesis (HP:0003302) | 2.37029509 |
| 79 | Cheilitis (HP:0100825) | 2.34128874 |
| 80 | Hand muscle atrophy (HP:0009130) | 2.30683006 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.30040069 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.29915612 |
| 83 | Abnormality of glycine metabolism (HP:0010895) | 2.29455893 |
| 84 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.29455893 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29055725 |
| 86 | Cellulitis (HP:0100658) | 2.26809200 |
| 87 | Xanthomatosis (HP:0000991) | 2.26648862 |
| 88 | Polygenic inheritance (HP:0010982) | 2.24871793 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24712943 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24712943 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24712943 |
| 92 | Upper motor neuron abnormality (HP:0002127) | 2.23337192 |
| 93 | Agammaglobulinemia (HP:0004432) | 2.23266955 |
| 94 | Gingivitis (HP:0000230) | 2.21926437 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 2.19602701 |
| 96 | Arterial thrombosis (HP:0004420) | 2.18628249 |
| 97 | Leukocytosis (HP:0001974) | 2.18615335 |
| 98 | Recurrent fungal infections (HP:0002841) | 2.18210173 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17932608 |
| 100 | Axonal loss (HP:0003447) | 2.17403690 |
| 101 | Hematochezia (HP:0002573) | 2.16136462 |
| 102 | Glomerulonephritis (HP:0000099) | 2.15299997 |
| 103 | Esophageal varix (HP:0002040) | 2.13719968 |
| 104 | T lymphocytopenia (HP:0005403) | 2.13650592 |
| 105 | Abnormality of T cell number (HP:0011839) | 2.12735341 |
| 106 | Malnutrition (HP:0004395) | 2.12717528 |
| 107 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.12566256 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 2.11762018 |
| 109 | Absent frontal sinuses (HP:0002688) | 2.11611653 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 2.11006817 |
| 111 | Upper limb amyotrophy (HP:0009129) | 2.11006817 |
| 112 | Hypoalphalipoproteinemia (HP:0003233) | 2.10852152 |
| 113 | Orchitis (HP:0100796) | 2.09498579 |
| 114 | Cerebral aneurysm (HP:0004944) | 2.09072048 |
| 115 | Rhabdomyolysis (HP:0003201) | 2.08497230 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 2.08139909 |
| 117 | Periodontitis (HP:0000704) | 2.07918378 |
| 118 | Myoglobinuria (HP:0002913) | 2.07453017 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 2.04993701 |
| 120 | Abnormality of the pleura (HP:0002103) | 2.04454400 |
| 121 | Chronic otitis media (HP:0000389) | 2.02778939 |
| 122 | Restrictive lung disease (HP:0002091) | 2.02703265 |
| 123 | Protuberant abdomen (HP:0001538) | 2.00087277 |
| 124 | Abnormality of purine metabolism (HP:0004352) | 1.98643057 |
| 125 | Polyneuropathy (HP:0001271) | 1.96699172 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.95699913 |
| 127 | Thoracic kyphosis (HP:0002942) | 1.93482942 |
| 128 | Abnormality of the endocardium (HP:0004306) | 1.92434422 |
| 129 | Hypertensive crisis (HP:0100735) | 1.91265143 |
| 130 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91241241 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90569464 |
| 132 | Obstructive lung disease (HP:0006536) | 1.90569464 |
| 133 | Amaurosis fugax (HP:0100576) | 1.90335283 |
| 134 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.89537892 |
| 135 | Gangrene (HP:0100758) | 1.88719223 |
| 136 | Abnormality of T cells (HP:0002843) | 1.88542127 |
| 137 | Hyperlipoproteinemia (HP:0010980) | 1.88521741 |
| 138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88319220 |
| 139 | Increased serum ferritin (HP:0003281) | 1.87664379 |
| 140 | Abnormal cartilage morphology (HP:0002763) | 1.87098120 |
| 141 | Spastic diplegia (HP:0001264) | 1.86875257 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.81668875 |
| 143 | Generalized amyotrophy (HP:0003700) | 1.79951689 |
| 144 | Toxemia of pregnancy (HP:0100603) | 1.79370484 |
| 145 | Proximal tubulopathy (HP:0000114) | 1.78461884 |
| 146 | Amyloidosis (HP:0011034) | 1.77202839 |
| 147 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77196317 |
| 148 | Abnormality of the nasal mucosa (HP:0000433) | 1.75733214 |
| 149 | Ventricular tachycardia (HP:0004756) | 1.74991800 |
| 150 | Neonatal death (HP:0003811) | 1.74827721 |
| 151 | Osteomyelitis (HP:0002754) | 1.74760949 |
| 152 | Peritonitis (HP:0002586) | 1.73852570 |
| 153 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.73539743 |
| 154 | Pulmonary embolism (HP:0002204) | 1.73117284 |
| 155 | Thrombocytosis (HP:0001894) | 1.72659062 |
| 156 | Oligomenorrhea (HP:0000876) | 1.71387720 |
| 157 | Delayed CNS myelination (HP:0002188) | 1.70778780 |
| 158 | Gout (HP:0001997) | 1.70567211 |
| 159 | Hepatosplenomegaly (HP:0001433) | 1.69780964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.23980215 |
| 2 | PKN2 | 3.67509699 |
| 3 | ERN1 | 3.51087797 |
| 4 | TRIB3 | 3.28447827 |
| 5 | MAP3K14 | 2.92465163 |
| 6 | PRPF4B | 2.83104930 |
| 7 | BCKDK | 2.71647474 |
| 8 | EPHB1 | 2.67959246 |
| 9 | MAP2K3 | 2.62479999 |
| 10 | TGFBR2 | 2.60800977 |
| 11 | MAP3K13 | 2.31477267 |
| 12 | BTK | 2.29152105 |
| 13 | LRRK2 | 2.25703024 |
| 14 | CAMK1D | 2.09612460 |
| 15 | STK10 | 2.02717804 |
| 16 | RIPK1 | 1.95509329 |
| 17 | TEC | 1.78016439 |
| 18 | FLT3 | 1.77283742 |
| 19 | TTN | 1.76021505 |
| 20 | TRPM7 | 1.72095325 |
| 21 | EEF2K | 1.69796399 |
| 22 | CDC42BPA | 1.68607910 |
| 23 | CSK | 1.68574361 |
| 24 | GRK7 | 1.66401061 |
| 25 | CSF1R | 1.65662784 |
| 26 | KIT | 1.51986966 |
| 27 | SIK1 | 1.50091402 |
| 28 | ZAP70 | 1.37663536 |
| 29 | TGFBR1 | 1.37485959 |
| 30 | TBK1 | 1.36875204 |
| 31 | IRAK3 | 1.34617173 |
| 32 | PAK4 | 1.34607436 |
| 33 | MAP2K4 | 1.33067760 |
| 34 | CAMKK2 | 1.31636751 |
| 35 | TIE1 | 1.31636443 |
| 36 | HCK | 1.30315571 |
| 37 | BLK | 1.30138619 |
| 38 | FGFR4 | 1.26962386 |
| 39 | TXK | 1.25409522 |
| 40 | FES | 1.20446267 |
| 41 | RPS6KA4 | 1.19656780 |
| 42 | MAP3K11 | 1.19007019 |
| 43 | PTK6 | 1.17146213 |
| 44 | TAOK2 | 1.14587918 |
| 45 | GRK6 | 1.11981693 |
| 46 | MATK | 1.10391580 |
| 47 | CAMK1G | 1.09793136 |
| 48 | DDR2 | 1.08387807 |
| 49 | FGR | 1.08315203 |
| 50 | RPS6KB2 | 1.08220127 |
| 51 | TYK2 | 1.07823921 |
| 52 | PIM2 | 1.05898319 |
| 53 | MAP3K10 | 1.05711004 |
| 54 | ITK | 1.01973420 |
| 55 | IRAK4 | 1.00877800 |
| 56 | KDR | 0.99534896 |
| 57 | JAK2 | 0.98122829 |
| 58 | MAP3K1 | 0.94323422 |
| 59 | RIPK4 | 0.91044772 |
| 60 | MAPK4 | 0.90314659 |
| 61 | TNK2 | 0.89815088 |
| 62 | JAK3 | 0.89379172 |
| 63 | PRKG2 | 0.88167359 |
| 64 | TAOK3 | 0.87606840 |
| 65 | SIK3 | 0.85998823 |
| 66 | ABL2 | 0.84750256 |
| 67 | MAPK7 | 0.81957805 |
| 68 | MOS | 0.81214248 |
| 69 | PIM1 | 0.79103378 |
| 70 | RET | 0.76916568 |
| 71 | CDK9 | 0.76492867 |
| 72 | MAP3K6 | 0.75005814 |
| 73 | SYK | 0.74832090 |
| 74 | SIK2 | 0.74598505 |
| 75 | KSR2 | 0.74140366 |
| 76 | RPS6KA6 | 0.71702734 |
| 77 | ILK | 0.71242119 |
| 78 | BMPR2 | 0.70491098 |
| 79 | CDK6 | 0.69811717 |
| 80 | YES1 | 0.69200407 |
| 81 | RPS6KC1 | 0.66613648 |
| 82 | RPS6KL1 | 0.66613648 |
| 83 | CDK7 | 0.66569026 |
| 84 | SMG1 | 0.66512681 |
| 85 | MST4 | 0.65820942 |
| 86 | IRAK1 | 0.64392095 |
| 87 | SCYL2 | 0.63632161 |
| 88 | MARK2 | 0.63519001 |
| 89 | IRAK2 | 0.63421993 |
| 90 | PDK1 | 0.63391452 |
| 91 | FGFR3 | 0.63097682 |
| 92 | MAP2K6 | 0.62444983 |
| 93 | MARK3 | 0.61757030 |
| 94 | RPS6KA2 | 0.60498499 |
| 95 | MAP3K5 | 0.60203758 |
| 96 | DAPK2 | 0.59572892 |
| 97 | TESK2 | 0.58942462 |
| 98 | MYLK | 0.58555048 |
| 99 | PDPK1 | 0.56765785 |
| 100 | MAPK12 | 0.56207772 |
| 101 | CHUK | 0.55888843 |
| 102 | PRKD2 | 0.55271562 |
| 103 | PRKCQ | 0.55071732 |
| 104 | ADRBK2 | 0.53292602 |
| 105 | ALK | 0.52879458 |
| 106 | ACVR1B | 0.51976104 |
| 107 | HIPK2 | 0.49376060 |
| 108 | FYN | 0.48715183 |
| 109 | PIK3CG | 0.48001266 |
| 110 | LYN | 0.47939381 |
| 111 | ARAF | 0.47456743 |
| 112 | CAMKK1 | 0.46873556 |
| 113 | PAK2 | 0.46193899 |
| 114 | EPHA3 | 0.45627844 |
| 115 | JAK1 | 0.45375408 |
| 116 | ABL1 | 0.45370491 |
| 117 | PRKAA2 | 0.44421046 |
| 118 | MAP3K3 | 0.44067506 |
| 119 | MAPKAPK2 | 0.40606691 |
| 120 | MAPKAPK3 | 0.40149999 |
| 121 | GSK3A | 0.39831918 |
| 122 | TAOK1 | 0.39404192 |
| 123 | BRSK2 | 0.38006098 |
| 124 | SGK3 | 0.37478915 |
| 125 | LCK | 0.35841496 |
| 126 | CDK12 | 0.34915275 |
| 127 | NME2 | 0.33668573 |
| 128 | MAP3K8 | 0.33115582 |
| 129 | EGFR | 0.32931387 |
| 130 | IKBKB | 0.32879106 |
| 131 | MAP3K7 | 0.32837106 |
| 132 | CDK4 | 0.31802499 |
| 133 | NEK9 | 0.30435005 |
| 134 | PTK2B | 0.30043350 |
| 135 | IKBKE | 0.29691237 |
| 136 | PTK2 | 0.29103624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.20770082 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.91481961 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90540889 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89291631 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.80474884 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69339813 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57655549 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54800205 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53187621 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.44447356 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38198342 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.35579877 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29895255 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24858851 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.10904589 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09277317 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00686917 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98029214 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.96603993 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.93138744 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92228190 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88964810 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.86357889 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76042416 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.71138601 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.65910575 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65290050 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60047873 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.58724156 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55492469 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54189686 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53399330 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48339429 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47350825 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.47304516 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44221427 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41804833 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36104769 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35642607 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.35128280 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.35027636 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34860020 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31634536 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29471935 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25494672 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.25339576 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24351516 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.24287308 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14493463 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.12794274 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11816186 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11028764 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.09114909 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09026983 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07109234 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.06533834 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05529501 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04329335 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02493378 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02093451 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 1.01562582 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.00896446 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00853346 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98194500 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.95368338 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.93793744 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93172619 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92546623 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90429841 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89849782 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.84936368 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84779945 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.83028930 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82222663 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81313142 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80899780 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80575709 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79956573 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79864689 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78781532 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77651710 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76892741 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73493734 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73049810 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72580853 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71636555 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68671413 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68163345 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68083709 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67013968 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64613698 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64086833 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64064651 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63503297 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63098274 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63093989 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61461374 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.59752514 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59461189 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59395976 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58980445 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57215370 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.56907979 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55430601 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55413579 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55338350 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.55095953 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54688632 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54330953 |
| 110 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53494289 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52946353 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52390655 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51487926 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49156628 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48675205 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48100788 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.47142130 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47101040 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.46240014 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45847720 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45261105 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.45148463 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.44900558 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44464110 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43289135 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43259521 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43258148 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43193217 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42521622 |
| 130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41920500 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40652875 |
| 132 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40477700 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40290406 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40081515 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40008493 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39988040 |
| 137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39698709 |
| 138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38369750 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.37224696 |
| 140 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36853324 |
| 141 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35356430 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33792539 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33673637 |
| 144 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33536998 |
| 145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31717871 |
| 146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25982832 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24825455 |
| 148 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22113435 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21530468 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20281869 |
| 151 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.20154408 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19328939 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18373989 |

